VR Mindfulness for People With HIV and Substance Use
Virtual Reality Mindfulness Intervention for Supporting People With HIV and Substance Use
2 other identifiers
interventional
30
0 countries
N/A
Brief Summary
The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems. Participants will:
- Use a VR headset with a mindfulness app at home;
- Complete three online surveys over three months;
- Take part in an individual interview or focus group to share their experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started Feb 2026
Shorter than P25 for not_applicable hiv
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2025
CompletedFirst Posted
Study publicly available on registry
July 28, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
July 28, 2025
July 1, 2025
1.2 years
July 19, 2025
July 19, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Intervention acceptability as measured by the Acceptability of Intervention Measure
The Acceptability of Intervention Measure is a 4-item scale that assesses the extent to which participants find the intervention agreeable or satisfactory. Items are rated on a 5-point Likert scale ranging from 1 (Completely disagree) to 5 (Completely agree). Scores are averaged to create a total score, with higher scores indicating greater perceived acceptability of the intervention. Example items include: "I like \[intervention\]" and "\[intervention\] meets my approval."
One-month follow-up
Intervention appropriateness as measured by the Intervention Appropriateness Measure
The Intervention Appropriateness Measure is a 4-item scale designed to assess how suitable or relevant the intervention is for the target population. Each item is rated from 1 (Completely disagree) to 5 (Completely agree), and a total score is calculated by averaging responses. Higher scores reflect a stronger belief that the intervention is appropriate for the individual's needs or situation. Example items include: "\[intervention\] seems like a good match" and "\[intervention\] seems suitable."
One-month follow up
Intervention feasibility as measured by the Feasibility of Intervention Measure
The Feasibility of Intervention Measure includes 4 items that measure how practical and doable the intervention seems from the participant's perspective. Participants respond on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree), with higher average scores indicating greater perceived feasibility. Example items include: "\[intervention\] seems implementable" and "\[intervention\] seems easy to use."
One-month follow up
Secondary Outcomes (1)
Intervention engagement as measured by VR mindfulness app use frequency
From enrollment to the end at 12 weeks.
Study Arms (1)
VR mindfulness
EXPERIMENTALParticipants in this arm will receive a virtual reality (VR) mindfulness intervention named TRIPP. TRIPP is a commercially available VR mindfulness app designed to promote relaxation, focus, and emotional well-being through immersive, guided experiences. The app combines visual and auditory stimulation, breathwork, meditation, and interactive elements to help users reduce stress and improve mood.
Interventions
In this study, participants will use TRIPP with a VR headset at home, engaging in short mindfulness sessions 3+ times per week for 4-12 weeks.
Eligibility Criteria
You may qualify if:
- Able to speak, read, and write in English
- Aged 18 years or older
- Diagnosed with HIV
- Currently prescribed ART therapy
- Reporting moderate to high risk related to alcohol, opioids, nicotine, cannabis, or stimulant use (score of 4 or higher on the Alcohol, Smoking, and Substance Involvement Screening Test - ASSIST). Participants may also use other substances, but the primary risk must fall within these categories, as these have the strongest research support for mindfulness-based interventions.
- Having stable housing that allow using VR safely
- Willing to provide contact information for at least one person whom the study team can reach if the participant becomes unreachable after repeated attempts
You may not qualify if:
- Living in institutionalized settings or unsheltered
- Terminal illness with a life expectancy of less than 6 months
- Planning to move out of the area in the next eight weeks
- Engaging in regular mindfulness practice outside of TRIPP
- Experiencing fear of closed spaces or unable to tolerate wearing a VR headset (verified during orientation session)
- Having visual or auditory impairments or severe physical disabilities that hinder VR use, history of seizures, severe cognitive impairment, severe motion sickness, severe unmanaged psychiatric symptoms, or currently pregnant
- Participants without home internet access will not be excluded and will be provided either funding for internet service or VR headsets preloaded with TRIPP sessions for offline use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 19, 2025
First Posted
July 28, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
July 28, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share